HANANE CHICHANE: Open Payments
NPI 1689677957 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 111 payments from 10 companies in 2025. Trend: 2023 $2,531 · 2024 $2,482 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $543 |
| Alkermes, Inc. | 8 | $251 |
| Otsuka America Pharmaceutical, Inc. | 12 | $241 |
| ABBVIE INC. | 16 | $225 |
| Almatica Pharma LLC | 8 | $190 |
| Supernus Pharmaceuticals, Inc. | 18 | $188 |
| Corium, LLC | 9 | $154 |
| Lundbeck LLC | 4 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $119 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
Products named: CAPLYTA, REXULTI, LYBALVI, VRAYLAR, Qelbree, LOREEV XR, Azstarys, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
